Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients. [electronic resource]
Producer: 20140922Description: 63-6 p. digitalISSN:- 1879-0828
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Benzamides -- therapeutic use
- Cohort Studies
- Comorbidity
- Drug Interactions
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Piperazines -- therapeutic use
- Polypharmacy
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- therapeutic use
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.